Vir Biotechnology (VIR) Change in Acquisitions & Divestments (2018 - 2026)

Vir Biotechnology has disclosed Change in Acquisitions & Divestments across 9 years of filings, most recently posting $170.6 million for Q1 2026.

• Change in Acquisitions & Divestments for Q1 2026 came in at $170.6 million, down 43.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 billion (down 26.09% YoY), and the FY2025 annual result was $1.2 billion, down 30.91% from the prior year.
• Change in Acquisitions & Divestments came in at $170.6 million for Q1 2026 at Vir Biotechnology, down from $342.9 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $715.7 million in Q4 2023 to a low of $84.8 million in Q3 2022.
• The 5-year median for Change in Acquisitions & Divestments is $342.9 million (2025), against an average of $377.6 million.
• Across the five-year window, Change in Acquisitions & Divestments soared 427.69% in 2023 and slumped 57.93% in 2024, its largest moves.
• Vir Biotechnology's Change in Acquisitions & Divestments stood at $266.7 million in 2022, then jumped by 168.39% to $715.7 million in 2023, then tumbled by 57.93% to $301.1 million in 2024, then advanced by 13.88% to $342.9 million in 2025, then plunged by 50.25% to $170.6 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $170.6 million (Q1 2026), $342.9 million (Q4 2025), and $305.2 million (Q3 2025), per Business Quant data.